基于新型冠状病毒肺炎定点医院的药事管理和药学服务实践  

Practice of Pharmaceutical Management and Pharmaceutical Care in the Designated Hospital of Novel Coronavirus Pneumonia

作　　者：刘异[1] 裘琳[1] 刘秀兰 杨婧雯 张程亮 王璐 李娟[1] 刘东[1] LIU Yi;QIU Lin;LIU Xiulan;YANG Jinwen;ZHANG Chengliang;WANG Lu;LI Juan;LIU Dong(Department of Pharmacy,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China)

机构地区：[1]华中科技大学同济医学院附属同济医院药学部,武汉430030

出　　处：《医药导报》2020年第4期522-527,共6页Herald of Medicine

摘　　要：武汉作为新型冠状病毒肺炎疫情的重灾区,为满足日益剧增的确诊患者得到更好救治,2020年1月25日,华中科技大学同济医学院附属同济医院中法新城院区被指定为武汉市新型冠状病毒肺炎危重症患者定点收治医院,全国18支医疗队在该院开展救治工作。在短时间内医院迅速改造为重症救治定点医院,收治危重症患者,用药需求量激增,药学保障和用药干预亟待解决。该文主要探讨在危重症定点医院药学部如何保障药品供应,统筹衔接和确保用药安全合理。Novel coronavirus pneumonia(NCP)broke out in Wuhan.As the hardest hit area of Wuhan,the growing number of confirmed cases need better therapy.On January 25,2020,the Sino-French New City Branch,Tongji Hospital of Huazhong University of Science and Technology was transformed into designated hospital for NCP.A total of 18 medical teams nationwide carried out treatment work here.In a short period of time,it was quickly transformed into a designated hospital for critical patients.Because most patients were critically ill,the demand for medication increased dramatically.How to guarantee the need of medication supply and pharmaceutical care became a urgent problem to be resolved.Our article mainly discussed how to ensure the supply of drug in designated hospital for critical patients,and how to ensure the safety and rationality of medication use.

关 键 词：新型冠状病毒肺炎 药事管理 药学服务 COVID-19危重症收治医院 

分 类 号：R951[医药卫生—药学] R511